DocGo Inc. Operating Lease Cost
DocGo Inc. (DCGO) reported Operating Lease Cost of $1.38 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-17
- DocGo Inc. operating lease, cost for the quarter ending 2026-06-30 was $1.38M, a 2.64% increase year-over-year.
- DocGo Inc. operating lease, cost for the quarter ending 2026-03-31 was $1.42M, a 7.35% increase year-over-year.
- DocGo Inc. operating lease, cost for the quarter ending 2025-12-31 was $1.36M, a 26.74% increase year-over-year.
- DocGo Inc. operating lease, cost for the quarter ending 2025-09-30 was $1.36M, a 34.40% increase year-over-year.
- DocGo Inc. operating lease, cost for fiscal 2025 was $5.39M, a 39.97% increase from fiscal 2024.
- DocGo Inc. operating lease, cost for fiscal 2024 was $3.85M, a 12.68% increase from fiscal 2023.
- DocGo Inc. operating lease, cost for fiscal 2023 was $3.42M, a 48.96% increase from fiscal 2022.
- DocGo Inc. operating lease, cost for fiscal 2022 was $2.29M, a 15.08% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.38M 10-Q · filed 2026-08-17 | $2.80M 10-Q · filed 2026-08-17 | $4.17M derived: sum of 3 quarters · filed 2026-08-17 | $5.52M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $1.42M 10-Q · filed 2026-05-11 | $2.78M derived: sum of 2 quarters · filed 2026-05-11 | $4.14M derived: sum of 3 quarters · filed 2026-05-11 | $5.49M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.72M derived: sum of 2 quarters · filed 2026-03-16 | $4.07M derived: sum of 3 quarters · filed 2026-08-17 | $5.39M 10-K · filed 2026-03-16 |
| 2025-09-30 | $1.36M 10-Q · filed 2025-11-10 | $2.71M derived: sum of 2 quarters · filed 2026-08-17 | $4.03M 10-Q · filed 2025-11-10 | $5.10M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $1.35M 10-Q · filed 2026-08-17 | $2.67M 10-Q · filed 2026-08-17 | $3.75M derived: sum of 3 quarters · filed 2026-08-17 | $4.76M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $1.32M 10-Q · filed 2026-05-11 | $2.40M derived: sum of 2 quarters · filed 2026-05-11 | $3.41M derived: sum of 3 quarters · filed 2026-05-11 | $4.24M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.08M derived: sum of 2 quarters · filed 2026-03-16 | $2.91M derived: sum of 3 quarters · filed 2026-03-16 | $3.85M 10-K · filed 2026-03-16 |
| 2024-09-30 | $1.01M 10-Q · filed 2025-11-10 | $1.84M derived: sum of 2 quarters · filed 2025-11-10 | $2.78M 10-Q · filed 2025-11-10 | $3.87M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $830.03K 10-Q · filed 2025-08-07 | $1.77M 10-Q · filed 2025-08-07 | $2.87M derived: sum of 3 quarters · filed 2026-03-16 | $3.56M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $936.75K 10-Q · filed 2025-05-08 | $2.04M derived: sum of 2 quarters · filed 2026-03-16 | $2.73M derived: sum of 3 quarters · filed 2026-03-16 | $3.60M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.80M derived: sum of 2 quarters · filed 2026-03-16 | $2.66M derived: sum of 3 quarters · filed 2026-03-16 | $3.42M 10-K · filed 2026-03-16 |
| 2023-09-30 | $697.05K 10-Q · filed 2024-11-07 | $1.56M derived: sum of 2 quarters · filed 2024-11-07 | $2.32M 10-Q · filed 2024-11-07 | $3.10M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $865.99K 10-Q · filed 2024-08-07 | $1.62M 10-Q · filed 2024-08-07 | $2.40M derived: sum of 3 quarters · filed 2025-02-27 | $3.03M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $756.25K 10-Q · filed 2024-05-08 | $1.53M derived: sum of 2 quarters · filed 2025-02-27 | $2.16M derived: sum of 3 quarters · filed 2025-02-27 | |
| 2022-12-31 | $777.10K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.40M derived: sum of 2 quarters · filed 2025-02-27 | $2.29M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $626.19K 10-Q · filed 2023-11-06 | $1.52M 10-Q · filed 2023-11-06 | ||
| 2021-12-31 | $1.99M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |